GlassScriptPhysician profile
Jennifer Meinhardt
NPI 1417311978
$937.81
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2021: $19.45 · 2022: $38.88 · 2023: $258 · 2024: $397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $655.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $176.14 | 2024 | Zoryve |
| Regeneron Healthcare Solutions, INC. | $131.37 | 2022-2023 | Dupixent |
| Melinta Therapeutics, LLC | $121.00 | 2019 | |
| Novo Nordisk INC | $120.85 | 2024 | Wegovy |
| Sun Pharmaceutical Industries INC. | $117.74 | 2023-2024 | Winlevi |
| Genzyme Corporation | $104.24 | 2021-2024 | |
| Allergan, INC. | $103.32 | 2019 | |
| Rxsight INC | $23.49 | 2023 | Rxsight Injector Cartridge, Rxsight Light Adjustable Lens (Rxlal), Rxsight Contact Lens |
| Journey Medical Corporation | $20.81 | 2024 | |
| Galderma Laboratories, L.P. | $18.85 | 2023 | Aklief, Twyneo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Meinhardt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.